AMP Annual Meeting & Expo
Held virtually this year, the AMP Annual Meeting & Expo hosted by the Association for Molecular Pathology, explored how cutting-edge technology and developments in molecular testing and diagnostics continue to have a major impact on patient care, and ways in which our community remains at the forefront of precision medicine.
Diana Richard
Director of Anatomic Pathology Program
XiFin, Inc.
Krista Nadolski
Director of Novel Diagnostics
XiFin, Inc.
The Association for Molecular Pathology (AMP) was founded in 1995 to provide structure and leadership to the emerging field of molecular diagnostics. AMP’s 2,500+ members include individuals from academic and community medical centers, government, and industry; including pathologist and doctoral scientist laboratory directors; basic and translational scientists; technologists; and trainees.
Through the efforts of its Board of Directors, Committees, Working Groups, and members, AMP is the primary resource for expertise, education, and collaboration in one of the fastest growing fields in healthcare. AMP members influence policy and regulation on the national and international levels, ultimately serving to advance innovation in the field and protect patient access to high quality, appropriate testing.